Gene · 7423
Papers4,111
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 4,111
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biomimetic scaffold-based stem cell transplantation promotes lung regeneration. | Bioeng Transl Med | 2023 | 37476061 | PubTator, text mining | PubMed |
| Pansclerotic morphea is characterized by IFN-γ responses priming dendritic cell fibroblast crosstalk to promote fibrosis. | JCI Insight | 2023 | 37471168 | PubTator, text mining | PubMed |
| Vascular endothelial growth factor gene insertion/deletion polymorphism is associated with Vitamin D level in Turkish patients with coronavirus disease 2019. | Rev Assoc Med Bras (1992) | 2023 | 37466590 | PubTator, text mining | PubMed |
| Molecular and cellular regulation of thermogenic fat. | Front Endocrinol (Lausanne) | 2023 | 37465124 | PubTator, text mining | PubMed |
| Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance. | J Exp Clin Cancer Res | 2023 | 37460927 | PubTator, text mining | PubMed |
| Tapping the potential of synthetic riboswitches: reviewing the versatility of the tetracycline aptamer. | RNA Biol | 2023 | 37459466 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors in ovarian cancer: where do we go from here? | Cancer Drug Resist | 2023 | 37457131 | PubTator, text mining | PubMed |
| Role of circulating CD14++CD16+ monocytes and VEGF-B186 in formation of collateral circulation in patients with hyperacute AMI. | Heliyon | 2023 | 37456037 | PubTator, text mining | PubMed |
| Comprehensive analysis of the oncogenic roles of vascular endothelial growth factors and their receptors in stomach adenocarcinoma. | Heliyon | 2023 | 37449140 | PubTator, text mining | PubMed |
| The Slow Progression of Diabetic Retinopathy Is Associated with Transient Protection of Retinal Vessels from Death. | Int J Mol Sci | 2023 | 37446043 | PubTator, text mining | PubMed |
| The Role of Targeted Therapy in the Multi-Disciplinary Approach to Colorectal Liver Metastasis. | Cancers (Basel) | 2023 | 37444625 | PubTator, text mining | PubMed |
| Soft Tissue Ewing Sarcoma Cell Drug Resistance Revisited: A Systems Biology Approach. | Int J Environ Res Public Health | 2023 | 37444135 | PubTator, text mining | PubMed |
| Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin. | Cells | 2023 | 37443817 | PubTator, text mining | PubMed |
| MicroRNAs in Tumor Endothelial Cells: Regulation, Function and Therapeutic Applications. | Cells | 2023 | 37443725 | PubTator, text mining | PubMed |
| Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma. | J Gastrointest Oncol | 2023 | 37435232 | PubTator, text mining | PubMed |
| VEGF Mediates Tumor Growth and Metastasis by Affecting the Expression of E-Cadherin and N-Cadherin Promoting Epithelial to Mesenchymal Transition in Gastric Cancer. | Clin Med Insights Oncol | 2023 | 37435016 | PubTator, text mining | PubMed |
| The Effect of Stem Cells and Vascular Endothelial Growth Factor on Cancer Angiogenesis. | Adv Biomed Res | 2023 | 37434939 | PubTator, text mining | PubMed |
| Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis. | BMC Med | 2023 | 37430350 | PubTator, text mining | PubMed |
| Effect of miR-4270 Suppression on Migration in Hepatocellular Carcinoma Cell Line (HepG2) | Iran Biomed J | 2023 | 37430248 | PubTator, text mining | PubMed |
| Aortic dissection induced by vascular endothelial growth factor inhibitors. | Front Pharmacol | 2023 | 37426822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7423/papers?page=20